$50K Michael Jordan Jersey turns into a $4.5M Jackpot Discovery using Real Game Used’s Patent Pending AI Technology

1 week ago

MESA, ARIZONA / ACCESS Newswire / January 8, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its…

NCQA Names Sarah E. Saxton as Senior Vice President of Quality Services

1 week ago

Saxton will lead NCQA's Quality Solutions Group, strengthening federal collaboration to drive health transformation WASHINGTON, DC / ACCESS Newswire /…

Cellev8 Nutrition Welcomes Dr. Guangshuo “Alan” Zhu, MD to Its Board of Directors

1 week ago

WELLINGTON, FLORIDA / ACCESS Newswire / January 8, 2026 / Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant…

Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

1 week ago

~ New ADHD pipeline leverages TAAP™ and MPAR® technologies to improve safety for patients ~ SAN DIEGO, CALIFORNIA / ACCESS…

Ascend Advanced Therapies – ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy

1 week ago

Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice…

FDA Clears Toetal Solution’s Ziptoe Hammertoe System

1 week ago

Company Positioned for Strategic Transaction MALVERN, PA / ACCESS Newswire / January 8, 2026 / Toetal Solution, Inc., a Runway…

Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T

1 week ago

1H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune Disease Interim Futility Analysis of…

Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates

1 week ago

Received $35.8 million in gross proceeds from Series B warrant exercises, including full exercise by Coastlands Capital, Frazier Life Sciences…

Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook

1 week ago

Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue1  IBSRELA achieved $274 million in revenue…